CFDE Data Portal | Search MRPL53P1

	Label	Description
	MRPL53P1 associations Collection (Entity type)	Associations for MRPL53P1_associations
	MRPL53P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MRPL53P1 Gene (Entity type)	ENSG00000235299 - mitochondrial ribosomal protein L53 pseudogene 1
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179332 STAT3 inhibition Reh 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE215461 topotecan 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	SUCNR1 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG

MRPL53P1 associations

Associations for MRPL53P1_associations

MRPL53P1 associations.tsv

A file from IDG as part of the Harmonizome project

MRPL53P1

ENSG00000235299 - mitochondrial ribosomal protein L53 pseudogene 1

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE195663 cisplatin 7 v 1 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 4 v 5 human dn

A Gene Set from LINCS

GSE100148 EZH2 inhibition 4 v 7 human dn

A Gene Set from LINCS

GSE179332 STAT3 inhibition Reh 0 v 1 human up

A Gene Set from LINCS

GSE215461 topotecan 0 v 1 human up

A Gene Set from LINCS

SUCNR1 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.